<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2023, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 08 Sep 2023 10:14:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  25-NSE     NYMOX PHARMACEUTICAL                   Filed by: Nasdaq Stock Market LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html</guid>
   <pubDate>Fri, 08 Sep 2023 10:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  25-NSE     NYMOX PHARMACEUTICAL                   Filed by: Nasdaq Stock Market LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++NYMOX+PHARMACEUTICAL+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/22141986.html</guid>
   <pubDate>Fri, 08 Sep 2023 10:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Aug 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html</guid>
   <pubDate>Tue, 29 Aug 2023 15:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Aug 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+29/22104213.html</guid>
   <pubDate>Tue, 29 Aug 2023 15:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html</guid>
   <pubDate>Mon, 14 Aug 2023 15:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jun+30/22041943.html</guid>
   <pubDate>Mon, 14 Aug 2023 15:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Aug 02</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html</guid>
   <pubDate>Wed, 02 Aug 2023 13:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Aug 02</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Aug+02/21985460.html</guid>
   <pubDate>Wed, 02 Aug 2023 13:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html</guid>
   <pubDate>Mon, 31 Jul 2023 13:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+31/21970837.html</guid>
   <pubDate>Mon, 31 Jul 2023 13:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html</guid>
   <pubDate>Tue, 25 Jul 2023 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944985.html</guid>
   <pubDate>Tue, 25 Jul 2023 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html</guid>
   <pubDate>Tue, 25 Jul 2023 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Form  6-K        NYMOX PHARMACEUTICAL      For: Jul 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++NYMOX+PHARMACEUTICAL++++++For%3A+Jul+25/21944958.html</guid>
   <pubDate>Tue, 25 Jul 2023 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nymox+Reports+Successful+New+NYMOZARFEX+%28TM%29+Long-Term+Prostate+Cancer+Treatment+Clinical+Trial+Results/21943167.html</guid>
   <pubDate>Tue, 25 Jul 2023 10:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
  <item>
   <title>Nymox Reports on U.S. Patent Issuances</title>
   <link>http://www.streetinsider.com/Press+Releases/Nymox+Reports+on+U.S.+Patent+Issuances/21918785.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nymox+Reports+on+U.S.+Patent+Issuances/21918785.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nymox+Reports+on+U.S.+Patent+Issuances/21918785.html</guid>
   <pubDate>Tue, 18 Jul 2023 10:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NYMX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32222683</category>
   	  </item>
 </channel>
</rss>
